Kathy Jackson

7PUBLICATIONS
13CO-AUTHORS
Aboriginal and Torres Strait Islander epidemiologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 26, 2023
Molecular epidemiology of hepatitis B among Indigenous Australians in Queensland and the Torres Strait Islands.

Margaret Littlejohn, Lesley-Anne Jaskowski, Ros Edwards

|Oct 27, 2022
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.

Man-Fung Yuen, Chi-Yi Chen, Chun-Jen Liu

|Aug 18, 2022
Assessment of the cobas® HBV RNA investigational assay in the setting of nucleoside analog therapy cessation.

Kathy Jackson, Sara Bonanzinga, Ros Edwards

|Nov 11, 2020
Real-world application of the Xpert® HBV viral load assay on serum and dried blood spots.

Kathy Jackson, Rosemary Tekoaua, Xin Li

|Apr 13, 2019
Evaluation of dried blood spots for hepatitis B and D serology and nucleic acid testing.

Kathy Jackson, Thomas Holgate, Rosemary Tekoaua

|May 16, 2018
Epidemiology and phylogenetic analysis of hepatitis D virus infection in Australia.

Kathy Jackson, Jennifer MacLachlan, Benjamin Cowie

Pageof 2

Frequent Collaborators

1 joint publications

Jennifer MacLachlan

1 joint publications

Robert Gish

1 joint publications

Man-Fung Yuen

1 joint publications

Wen-Juei Jeng